A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients

BACKGROUND: Adrenal androgens play an important role in the development of castration-resistant prostate cancer therapeutics. The effect of gonadotropin-releasing hormone (GnRH) antagonists on adrenal androgens has not been studied sufficiently. We measured testicular and adrenal androgen levels in...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Urol
Glavni autori: Miyazawa, Yoshiyuki, Sekine, Yoshitaka, Syuto, Takahiro, Nomura, Masashi, Koike, Hidekazu, Matsui, Hiroshi, Shibata, Yasuhiro, Ito, Kazuto, Suzuki, Kazuhiro
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5575925/
https://ncbi.nlm.nih.gov/pubmed/28851333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-017-0261-z
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items